Stanford Grads’ Tampon Startup Takes on Growing Market

Why It Matters

Reliable menstrual products can keep girls in sports, addressing a key dropout factor and opening a fast‑growing $12 billion market for specialized feminine‑hygiene solutions.

Key Takeaways

• Sequel raised over $8 million from venture investors
• Spiral tampon design redirects fluid to core
• FDA approved in 2023, Class II medical device
• Partnerships with Yankees, D.C. United, Indiana Fever

Pulse Analysis

The feminine‑hygiene sector is on a rapid expansion trajectory, with forecasts showing the tampon market climbing from $7.44 billion this year to $12.61 billion by 2034. Dominated by legacy brands such as Procter & Gamble’s Tampax and Johnson & Johnson’s O.B., the space has seen little product innovation since the 1930s. This market inertia creates a fertile opening for startups that can marry engineering rigor with consumer‑centric design, especially as athletes demand performance‑grade solutions that match their sports gear.

Sequel’s breakthrough lies in its spiral‑shaped tampon, a mechanical‑engineered redesign that channels menstrual fluid toward the absorbent core, reducing edge leakage that plagues traditional vertical‑channel products. Developed over five years by Stanford mechanical engineers, the design underwent extensive testing to meet Class II medical‑device standards, culminating in FDA clearance in 2023. By solving a pain point that forces up to 78 % of young women to avoid sports during their periods, the product not only promises comfort but also addresses a documented driver of female athletic attrition.

From a business perspective, Sequel has leveraged $8 million in seed‑stage capital to secure strategic distribution through high‑traffic venues like Yankee Stadium, reaching roughly 1.5 million women annually. The partnership model, replicated with D.C. United and the Indiana Fever, provides brand visibility while bypassing traditional retail channels. As the company eyes a Series A round, scaling production, expanding e‑commerce presence, and broadening sports affiliations will be critical to capture market share from entrenched incumbents and to cement its role as the go‑to performance tampon for athletes worldwide.